prednisone has been researched along with Optic Neuropathy, Ischemic in 33 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Optic Neuropathy, Ischemic: Ischemic injury to the OPTIC NERVE which usually affects the OPTIC DISK (optic neuropathy, anterior ischemic) and less frequently the retrobulbar portion of the nerve (optic neuropathy, posterior ischemic). The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. (Glaser, Neuro-Ophthalmology, 2nd ed, p135)
| Excerpt | Relevance | Reference |
|---|---|---|
| " There were no perioperative or postoperative complications in the 15 eyes that underwent cataract surgery with varying doses of prednisone at the time of surgery (1 to 25 mg daily prednisone ± 10 to 25 mg weekly methotrexate; median prednisone dose of 10." | 4.02 | Timing of cataract surgery in patients with giant cell arteritis. ( Chacko, JG; Fong, JW, 2021) |
| "A patient with arteriosclerosis, diabetes mellitus, and giant cell arteritis (GCA) treated continuously with low-dose prednisone developed anterior ischemic optic neuropathy (AION) at 5 and 13 months after clinical diagnosis of GCA." | 3.72 | Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. ( Flint, A; Keoleian, G; Kim, N; Trobe, JD, 2003) |
| "Despite receiving high-dose intravenous methylprednisolone and oral prednisone for biopsy-proven giant cell arteritis that presented as a severe anterior ischemic optic neuropathy in the right eye, a patient developed progressive ocular ischemia in that eye as well as an ocular ischemic syndrome in the fellow eye." | 3.70 | Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. ( Girkin, CA; Hellmann, DB; Hwang, JM; Lai, JC; Miller, NR; Perry, JD, 1999) |
| "Anterior ischemic optic neuropathy was the dominant mechanism of vision loss." | 2.82 | Vision loss in giant cell arteritis: case-based review. ( Aligianni, SI; Daoussis, D; Kokloni, IN; Makri, O, 2022) |
| "To report a case of non-arteritic anterior ischemic optic neuropathy (NAAION) with macular star after receiving the second dose of SARS-CoV-2 vaccination." | 1.72 | Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination. ( Elhusseiny, AM; Sallam, AB; Sanders, RN; Siddiqui, MZ, 2022) |
| "Nonarteritic acute anterior ischemic optic neuropathy (NAION) is a disabling disease which impairs visual function." | 1.33 | LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy. ( Capurso, A; Coratelli, P; Giancipoli, G; Guerriero, S; Lapenna, L; Ramunni, A; Saliani, MT; Saracino, A; Sborgia, C, 2005) |
| "Giant cell arteritis is a systemic vasculitis that affects large- and medium sized arteries." | 1.33 | [Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report]. ( Budrowski, R; Mariak, Z; Obuchowska, I, 2006) |
| "Two patients with non-arteritic anterior ischemic optic neuropathy due to a high-grade ophthalmic artery stenosis were treated with HBO at 2 atm abs in an effort to increase oxygen delivery for the eye." | 1.31 | Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone. ( Bojić, L; Gosović, G; Ivanisević, M, 2002) |
| "One hundred seventy-four patients with temporal arteritis (147 biopsy proven) were prospectively observed for the development of permanent visual loss." | 1.31 | Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. ( Herrmann, F; Liozon, E; Loustaud, V; Ly, K; Robert, PY; Soria, P; Vidal, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 15 (45.45) | 29.6817 |
| 2010's | 10 (30.30) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Elhusseiny, AM | 1 |
| Sanders, RN | 1 |
| Siddiqui, MZ | 1 |
| Sallam, AB | 1 |
| Kokloni, IN | 1 |
| Aligianni, SI | 1 |
| Makri, O | 1 |
| Daoussis, D | 1 |
| Fong, JW | 1 |
| Chacko, JG | 1 |
| Herbaut, A | 1 |
| Qu-Knafo, L | 1 |
| Abad, S | 1 |
| Dhote, R | 1 |
| Giocanti-Aurégan, A | 1 |
| Al Zubidi, N | 1 |
| Zhang, J | 1 |
| Spitze, A | 1 |
| Yalamanchili, S | 1 |
| Lee, AG | 2 |
| Biousse, V | 1 |
| Chen, JJ | 1 |
| Kardon, RH | 3 |
| Daley, TJ | 1 |
| Longmuir, RA | 1 |
| Mednick, Z | 1 |
| Farmer, J | 1 |
| Khan, Z | 1 |
| Warder, D | 1 |
| Ten Hove, M | 1 |
| Seth, A | 1 |
| Anderson, DP | 1 |
| Albiani, DA | 1 |
| Barton, JJ | 1 |
| Knyazer, B | 1 |
| Lifshitz, T | 1 |
| Marcus, M | 1 |
| Kratz, A | 1 |
| Zlotnik, A | 1 |
| Levy, J | 1 |
| Pelegrín, L | 1 |
| Mesquida, M | 1 |
| Rey, A | 1 |
| Sánchez-Dalmau, B | 1 |
| Frohman, L | 1 |
| Rebolleda, G | 1 |
| Pérez-López, M | 1 |
| Casas-Llera, P | 1 |
| Muñoz-Negrete, FJ | 1 |
| Vallet, AE | 1 |
| Didelot, A | 1 |
| Guebre-Egziabher, F | 1 |
| Bernard, M | 1 |
| Mauguière, F | 1 |
| Thurtell, MJ | 1 |
| Hayreh, SS | 3 |
| Zimmerman, B | 1 |
| Bojić, L | 1 |
| Ivanisević, M | 1 |
| Gosović, G | 1 |
| Foroozan, R | 1 |
| Deramo, VA | 1 |
| Buono, LM | 1 |
| Jayamanne, DG | 1 |
| Sergott, RC | 1 |
| Danesh-Meyer, H | 1 |
| Savino, PJ | 1 |
| Sinnreich, M | 1 |
| Rossillion, B | 1 |
| Landis, T | 1 |
| Burkhard, PR | 1 |
| Sztajzel, R | 1 |
| Kim, N | 1 |
| Trobe, JD | 1 |
| Flint, A | 1 |
| Keoleian, G | 1 |
| Agard, C | 1 |
| Barrier, JH | 1 |
| Ramunni, A | 1 |
| Giancipoli, G | 1 |
| Guerriero, S | 1 |
| Lapenna, L | 1 |
| Saracino, A | 1 |
| Saliani, MT | 1 |
| Capurso, A | 1 |
| Sborgia, C | 1 |
| Coratelli, P | 1 |
| Bandini, F | 1 |
| Benedetti, L | 1 |
| Ceppa, P | 1 |
| Corallo, G | 1 |
| Khurma, V | 1 |
| Appen, R | 1 |
| Wolf, MD | 1 |
| Hansen, KE | 1 |
| Obuchowska, I | 1 |
| Mariak, Z | 1 |
| Budrowski, R | 1 |
| Zimmerman, MB | 2 |
| Hernández-Rodríguez, J | 1 |
| Font, C | 1 |
| García-Martínez, A | 1 |
| Espígol-Frigolé, G | 1 |
| Sanmartí, R | 1 |
| Cañete, JD | 1 |
| Grau, JM | 1 |
| Cid, MC | 1 |
| Meli, B | 1 |
| Landau, K | 1 |
| Gloor, BP | 1 |
| Diego, M | 1 |
| Margo, CE | 1 |
| Korzets, Z | 1 |
| Zeltzer, E | 1 |
| Rathaus, M | 1 |
| Manor, R | 1 |
| Bernheim, J | 1 |
| Hwang, JM | 1 |
| Girkin, CA | 1 |
| Perry, JD | 1 |
| Lai, JC | 1 |
| Miller, NR | 1 |
| Hellmann, DB | 1 |
| Liozon, E | 1 |
| Herrmann, F | 1 |
| Ly, K | 1 |
| Robert, PY | 1 |
| Loustaud, V | 1 |
| Soria, P | 1 |
| Vidal, E | 1 |
4 reviews available for prednisone and Optic Neuropathy, Ischemic
| Article | Year |
|---|---|
Vision loss in giant cell arteritis: case-based review.
Topics: Aged; Blindness; Giant Cell Arteritis; Humans; Male; Optic Neuropathy, Ischemic; Prednisone; Vision | 2022 |
Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.
Topics: Aged; Aged, 80 and over; Biopsy; Dexamethasone; Female; Giant Cell Arteritis; Glucocorticoids; Human | 2002 |
Recovery of visual function in patients with biopsy-proven giant cell arteritis.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Infusions, I | 2003 |
[Complicated Horton's syndrome: therapeutic modalities].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anticoagulants; Drug Resistance; Giant Cell Arter | 2004 |
29 other studies available for prednisone and Optic Neuropathy, Ischemic
| Article | Year |
|---|---|
Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination.
Topics: BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; | 2022 |
Timing of cataract surgery in patients with giant cell arteritis.
Topics: Aged; Cataract; Female; Giant Cell Arteritis; Humans; Optic Neuropathy, Ischemic; Prednisone; Retros | 2021 |
[Bilateral acute arteritic anterior ischemic optic neuropathy during chronic steroid therapy].
Topics: Aged, 80 and over; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Optic Neuropathy, Ischemic; | 2017 |
Pallid disc edema and choroidal perfusion delay in posthemodialysis nonarteritic ischemic optic neuropathy.
Topics: Choroid; Fluorescein Angiography; Giant Cell Arteritis; Glucocorticoids; Humans; Kidney Failure, Chr | 2013 |
Commentary.
Topics: Female; Glucocorticoids; Humans; Male; Optic Neuropathy, Ischemic; Prednisone | 2014 |
Enhancement of the optic nerve sheath and temporal arteries from giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Optic Nerve | 2015 |
Coronary arteritis: An entity to be considered in giant cell arteritis.
Topics: Aged; Aortitis; Coronary Artery Disease; Fatal Outcome; Female; Giant Cell Arteritis; Glucocorticoid | 2016 |
Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Diphosphonates; Dru | 2009 |
Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Glucocorticoids; Hepatitis C; Humans; Interferon | 2011 |
Blind runner.
Topics: Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Hum | 2012 |
Treatment of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids.
Topics: Female; Glucocorticoids; Humans; Male; Optic Neuropathy, Ischemic; Prednisone | 2013 |
Initial neuro-ophthalmological manifestations in Churg-Strauss syndrome.
Topics: Aged; Anti-Inflammatory Agents; Blindness; Churg-Strauss Syndrome; Cyclophosphamide; Diplopia; Drug | 2010 |
Recovery of vision from no light perception in giant cell arteritis.
Topics: Administration, Oral; Aged; Biopsy; Blindness; Female; Fluorescein Angiography; Giant Cell Arteritis | 2012 |
Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone.
Topics: Anti-Inflammatory Agents; Constriction, Pathologic; Humans; Hyperbaric Oxygenation; Male; Middle Age | 2002 |
Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodies.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Cardiolipins; Diabetes Mellitus; Diagnosis, | 2003 |
Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Administration Schedule; Fundus Oculi; Giant | 2003 |
LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy.
Topics: Blood Component Removal; Cholesterol, LDL; Female; Fibrinogen; Humans; Male; Microcirculation; Middl | 2005 |
Uveitis as a presenting sign of giant cell arteritis.
Topics: Aged; Biopsy; Blindness; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Optic Neuropathy, Is | 2005 |
Wegener granulomatosis presenting as bilateral loss of vision.
Topics: Blindness; Cyclophosphamide; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppre | 2005 |
[Anterior ischemic optic neuropathy associated with giant cell arteritis. Case report].
Topics: Blindness; Giant Cell Arteritis; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Prednisone; | 2006 |
Optic disc edema in non-arteritic anterior ischemic optic neuropathy.
Topics: Aged; Diabetes Mellitus; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; Middle Aged | 2007 |
Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blindness; Female; Giant Cell Arteritis; Gluco | 2007 |
Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy.
Topics: Acute Disease; Arteritis; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Opt | 2008 |
Reversible loss of vision due to posterior ischemic optic neuropathy.
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blindness | 1995 |
[The bane of giant cell arteritis from an ophthalmological viewpoint].
Topics: Aged; Aged, 80 and over; Blindness; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; | 1996 |
Postural vision loss in giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Humans; Hypotension, Orthostatic; Male; Methylprednisolone; Opti | 1998 |
Uremic optic neuropathy. A uremic manifestation mandating dialysis.
Topics: Adult; Diagnosis, Differential; Glucocorticoids; Humans; Male; Methylprednisolone; Optic Nerve Disea | 1998 |
Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.
Topics: Administration, Oral; Aged; Blindness; Disease Progression; Eye; Female; Giant Cell Arteritis; Human | 1999 |
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Female; Giant Cell Arteritis; Humans; Mal | 2001 |